Arkolith/Insider Trading/NBP/Form 4

Cao Sean Wuxiong

Chief Bus. Development Officer, DirectorNovaBridge Biosciences (NBP) · full profile →Form 4 · filed Jun 24, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 22, 2026Grant(A)181K—$0181K
Jun 22, 2026Grant(A)181K—$0181K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002109966-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML